Table 3.
The biometric parameters of the dominant eyes or non-dominant eyes before and after the Implantable Collamer Lens (ICL) V4c implantation or Femtosecond Laser-Assisted Laser in Situ Keratomileusis (FS-LASIK).
| Parameters | D- or nD-eye | Preoperative/1-mon follow-up (Vault) | 54-mon follow-up | ||||
|---|---|---|---|---|---|---|---|
| ICL V4c Group | FS-LASIK Group | P | ICL V4c Group | FS-LASIK Group | P | ||
| ACD (mm) | D-eye | 3.23 ± 0.32 | 2.93 ± 0.18 | 0.013 | 2.95 ± 0.31△ | 2.86 ± 0.20 | 0.419 |
| nD-eye | 3.18 ± 0.33 | 2.94 ± 0.24 | 0.041 | 2.87 ± 0.32△ | 2.86 ± 0.25 | 0.980 | |
| ACV (μl) | D-eye | 180.90 ± 34.45 | 165.83 ± 26.48 | 0.344 | 110.92 ± 19.62△ | 158.27 ± 30.74 | < 0.001 |
| nD-eye | 167.00 ± 31.53 | 168.83 ± 32.03 | 0.849 | 106.33 ± 21.41△ | 158.73 ± 32.84 | < 0.001 | |
| ACA (°) | D-eye | 39.02 ± 5.82 | 34.00 ± 5.55 | 0.046 | 22.13 ± 3.92△ | 34.65 ± 5.13 | < 0.001 |
| nD-eye | 37.68 ± 5.72 | 34.48 ± 6.05 | 0.223 | 23.50 ± 4.81△ | 33.15 ± 5.84 | < 0.001 | |
| CT (μm) | D-eye | 530.33 ± 37.26 | 541.92 ± 22.24 | 0.375 | 536.58 ± 38.07 | 454.08 ± 33.92△ | < 0.001 |
| nD-eye | 535.25 ± 39.63 | 544.67 ± 23.53 | 0.470 | 531.92 ± 50.83 | 460.83 ± 38.74△ | < 0.001 | |
| IOP (mmhg) | D-eye | 15.05 ± 2.64 | 16.41 ± 3.07 | 0.007 | 15.71 ± 2.40△ | 11.64 ± 2.87△ | 0.007 |
| nD-eye | 15.17 ± 2.25 | 16.16 ± 3.43 | 0.023 | 16.12 ± 2.00△ | 11.57 ± 1.89△ | 0.029 | |
| AL (mm) | D-eye | 28.34 ± 2.18 | 26.13 ± 1.19 | 0.007 | 28.64 ± 2.33 | 26.38 ± 1.06 | 0.007 |
| nD-eye | 28.60 ± 2.09 | 26.78 ± 1.97 | 0.023 | 28.97 ± 2.27 | 27.16 ± 1.91 | 0.029 | |
| ECD (cell/mm2) | D-eye | 3144.42 ± 597.62 | NA | 2555.42 ± 295.80▲ | NA | ||
| nD-eye | 3122.67 ± 602.43 | 2564.42 ± 278.34▲ | |||||
| Vault (μm) | D-eye | 559.17 ± 193.08 | NA | 482.50 ± 220.58▲ | NA | ||
| nD-eye | 547.50 ± 167.66 | 489.17 ± 172.28▲ | |||||
ACD, anterior chamber depth; ACV, anterior chamber volume; ACA, anterior chamber angle; CT, corneal thickness; IOP, intraocular pressure; ECD, endothelium cell density.
△ versus Preoperative, P < 0.05. ▲ versus the 1-month follow-up, P < 0.05. * dominant eye versus nondominant eye, P < 0.05.
Values with statistical significance are shown in bold.